文献速递腹部CT

胰腺腺癌:定量CT特征与纤维性间质分数相关并有助于预测切除术后结局

Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection.
PubMed 文献 · Eur Radiol · 2020-04-28

回顾性纳入两个独立队列(发现队列212例、测试队列100例)行胰头PDAC(≤30mm)切除术前CE-CT,分析肿瘤与周围胰腺的衰减差异及跨期衰减变化。delta 3是最具决定性的影像特征(DFS HR=2.122,OS HR=2.375,均p<0.001),高delta 3肿瘤与更侵袭性组织学分级及较少纤维性间质分数相关。低delta 3且肿瘤≤20mm者结局最佳(DFS 36个月,OS 42个月),高delta 3者无论肿瘤大小结局均差(DFS 12个月,OS 19个月)。

要点

  • delta 3(胰腺期肿瘤与周围胰腺衰减差)是最具决定性的预后影像特征。
  • 高delta 3肿瘤与更侵袭性组织学分级及较少纤维性间质分数显著相关。
  • 低delta 3且肿瘤≤20mm者DFS 36个月、OS 42个月,高delta 3者DFS 12个月、OS 19个月。

关键影像表现/征象

  • delta 3表示胰腺期肿瘤与周围胰腺之间的衰减差异。
  • 高delta 3(≥28 HU)肿瘤较不显著(低delta 3,<28 HU)肿瘤与更侵袭性组织学分级显著相关(p=0.014)。
  • 高delta 3肿瘤较低delta 3肿瘤纤维性间质分数更少(p<0.001)。
  • 高delta 3意味着肿瘤与周围胰腺之间对比更锐利。

诊断标准与关键数值

  • delta 3为胰腺期肿瘤与周围胰腺的衰减差异,高delta 3定义为≥28 HU,低delta 3定义为<28 HU。
  • delta 3对DFS的HR=2.122(p<0.001),对OS的HR=2.375(p<0.001)。
  • 结合临床病理特征后,影像特征对DFS的C-index为发现队列0.766、测试队列0.739,对OS的C-index为发现队列0.790、测试队列0.772。
  • 低delta 3且肿瘤≤20mm者DFS 36个月、OS 42个月;高delta 3者DFS 12个月、OS 19个月。

临床应用与阅片要点

  • 阅片时可测量胰腺期肿瘤与周围胰腺的衰减差异(delta 3),高delta 3提示肿瘤与周围胰腺对比更锐利。
  • 高delta 3与更侵袭性组织学分级及较少纤维性间质分数相关,可辅助预后分层。
  • 结合肿瘤大小分层:低delta 3且≤20mm者结局最佳,高delta 3者无论大小结局均差。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To identify quantitative imaging features of contrast-enhanced computed tomography (CE-CT) that may be prognostically favorable after resection of smaller (≤ 30 mm) pancreatic ductal adenocarcinomas (PDACs) located at head.

METHODS: This retrospective study included two independent cohorts (discovery cohort, n = 212; test cohort, n = 100) of patients who underwent resection of head PDACs ≤ 30 mm and preoperative CE-CT. We examined tumor and surrounding parenchymal attenuation differences (deltas), and tumor attenuation changes across phases (ratios). Semantic features of PDACs were evaluated by two radiologists. Clinicopathologic and imaging features for predicting disease-free survival (DFS) and overall survival (OS) were analyzed via multivariate Lasso-penalized Cox proportional-hazards models. Survival rates were derived by Kaplan-Meier method.

RESULTS: Imaging features achieved C-indices of 0.766 (discovery cohort) and 0.739 (test cohort) for DFS, and 0.790 (discovery cohort) and 0.772 (test cohort) for OS estimates through incorporation of clinicopathologic features. The most decisive imaging feature was delta 3, denoting attenuation differences between tumor and surrounding pancreas at pancreatic phase (DFS: HR = 2.122; OS: HR = 2.375; both p < 0.001). Compared with inconspicuous (low-delta-3, < 28 HU) tumors, conspicuous (high-delta-3) tumors correlated significantly with more aggressive histologic grades (p = 0.014) and less extensive tumor fibrous stromal fractions (p < 0.001). Patients with low-delta-3 tumors ≤ 20 mm experienced the most favorable outcomes (DFS, 36 months; OS, 42 months), whereas those with high-delta-3 tumors fared poorly, regardless of tumor size (DFS, 12 months; OS, 19 months).

CONCLUSIONS: Quantifiable CT imaging features reflect heterogeneous fibrous stromal fractions and histologic grades of PDAC at head locations that help stratify patients with disparate clinical outcomes.

KEY POINTS: • Quantitative and semantic imaging features achieved promising results for the prognosis of resected PDAC (≤ 30 mm) at head location, through incorporation of clinicopathologic features. • Attenuation difference at tumor-parenchyma interface (delta 3) emerged as the most decisive imaging feature, enabling further stratification of patients into distinct prognostic subtypes by tumor size. • High delta 3 signifies sharper contrast between tumor and surrounding pancreas, correlating with more aggressive histologic grades and less extensive tumor fibrous stromal fractions.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Cai X, Gao F, Qi Y, et al. Pancreatic adenocarcinoma: quantitative CT features are correlated with fibrous stromal fraction and help predict outcome after resection. Eur Radiol. 2020. PMID: 32346792. doi:10.1007/s00330-020-06853-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。